Maisie GV Stevens

Also affiliated with UCSF Helen Diller Family Comprehensive Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “The Mac1 ADP-ribosylhydrolase is a therapeutic target for SARS-CoV-2”.

The Mac1 ADP-ribosylhydrolase is a therapeutic target for SARS-CoV-2

eLife(2025)10.7554/elife.103484.3

N/A

0.104DataRank · unranked

1 citations

Priyadarshini Jaishankar, G.J. Correy, Moira Rachman, Patrick C. O’Leary, Taha Y. Taha +26 more

AcrIF11 is a potent CRISPR-specific ADP-ribosyltransferase encoded by phage and plasmid

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.08.26.609590

N/A

0DataRank · unranked

0 citations

Leah T. Roe, Yuping Li, Adair L. Borges, Jenny Y. Zhang, Palak Babbar +11 more

AcrIF11 is a potent CRISPR-specific ADP-ribosyltransferase encoded by phage and plasmid

mBio(2025)10.1128/mbio.01698-25

N/A

0DataRank · unranked

4 citations

Leah T. Roe, Yuping Li, Adair L. Borges, Jenny Y. Zhang, Palak Babbar +11 more

Extensive exploration of structure activity relationships for the SARS-CoV-2 macrodomain from shape-based fragment merging and active learning

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.08.25.609621

N/A

0DataRank · unranked

9 citations

Moira Rachman, Takaya Togo, Stefan Gahbauer, Yagmur U. Doruk, Maisie GV Stevens +12 more

The Mac1 ADP-ribosylhydrolase is a therapeutic target for SARS-CoV-2

eLife(2025)10.7554/elife.103484

N/A

0DataRank · unranked

7 citations

Priyadarshini Jaishankar, G.J. Correy, Moira Rachman, Patrick C. O’Leary, Taha Y. Taha +26 more

Discovery of AVI-6451, a Potent and Selective Inhibitor of the SARS-CoV-2 ADP-Ribosylhydrolase Mac1 with Oral Efficacy in vivo

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.10.11.681833

N/A

0DataRank · unranked

3 citations

G.J. Correy, Yusuke Matsui, Takaya Togo, Moira Rachman, Maisie GV Stevens +14 more

Reviewer #2 (Public review): The Mac1 ADP-ribosylhydrolase is a Therapeutic Target for SARS-CoV-2

(2025)10.7554/elife.103484.1.sa1

N/A

0DataRank · unranked

0 citations

Priyadarshini Jaishankar, Galen J Correy, Moira M Rachman, Patrick C O’Leary, Taha Y Taha +22 more